Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Cytokine Immunotherapy chevron_right
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Cytokine Immunotherapy chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Parkinson's Diseasechevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Fabry Disease chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Home
    • Access All Programs
    • Specialtieschevron_right
      • chevron_leftTopics
      • Cardiology
      • Diabetes
      • Endocrinology
      • Neurology
      • Cancer
      • Primary Care
      • Dermatology
      • Biologics
      • MAC Lung Disease
    • Submit A Question
    close

    Alberto Ortiz, MD

    Alberto Ortiz, MD

    Chief of Nephrology and Hypertension
    Renal Unit, IIS-Fundacio?n Jime?nez Di?az
    Universidad Auto?noma de Madrid, FRIAT
    Madrid, Spain


    Related Videos

    Can you summarize the pathophysiology and pathobiology of renal impairment, and associated findings—in particular, albuminuria—on renal function testing, in the setting of Fabry Disease? Video

    Can you summarize the pathophysiology and pathobiology of renal impairment, and associated findings—in particular, albuminuria—on renal function testing, in the setting of Fabry Disease?

    What is the role of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations in the pathology—including, as soluble, circulating mediators—of renal disease in FD? Video

    What is the role of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations in the pathology—including, as soluble, circulating mediators—of renal disease in FD?

    Can you construct a diagnostic roadmap—including family history, symptom complexes, and/or biomarker manifestations—for the nephrologist that will optimize detection of FD at the front lines of practice? Video

    Can you construct a diagnostic roadmap—including family history, symptom complexes, and/or biomarker manifestations—for the nephrologist that will optimize detection of FD at the front lines of practice?

    What other target organs should be evaluated to corroborate the diagnosis? What is the “pathologic march” of FD and what is the sequence of target organ deterioration in males with classic disease vs. females? Video

    What other target organs should be evaluated to corroborate the diagnosis? What is the “pathologic march” of FD and what is the sequence of target organ deterioration in males with classic disease vs. females?

    Do all patients with FD have the same propensity to develop Fabry renal disease, and how does the male/female incidence discordance help us make the diagnosis? Video

    Do all patients with FD have the same propensity to develop Fabry renal disease, and how does the male/female incidence discordance help us make the diagnosis?

    Can you summarize the current guidelines and/or recommendations from Europe and the U.S. for diagnostic evaluation and treatment of FD? Video

    Can you summarize the current guidelines and/or recommendations from Europe and the U.S. for diagnostic evaluation and treatment of FD?

    How early in childhood are the renal manifestations present in classic Fabry in males? What is the natural history of renal dysfunction and what specific metrics related to albuminuria/proteinuria should be followed and increase suspicion of FD? Video

    How early in childhood are the renal manifestations present in classic Fabry in males? What is the natural history of renal dysfunction and what specific metrics related to albuminuria/proteinuria should be followed and increase suspicion of FD?

    What is your systematic, step-by-step diagnostic work-up for a young/adolescent male in whom the diagnosis of FD must be considered and/or ruled out? What genetic tests should be performed? Video

    What is your systematic, step-by-step diagnostic work-up for a young/adolescent male in whom the diagnosis of FD must be considered and/or ruled out? What genetic tests should be performed?

    What are the key diagnostic parameters—specifically, urinary and related renal biomarkers, including albuminuria and creatine—that should increase awareness of and prompt evaluation and further genetic testing for Fabry disease? Video

    What are the key diagnostic parameters—specifically, urinary and related renal biomarkers, including albuminuria and creatine—that should increase awareness of and prompt evaluation and further genetic testing for Fabry disease?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED